Compounding pharmacies in Michigan
By the PeptideAgent Editorial Team. Draft, pending editorial review. Last verified
The Michigan Board of Pharmacy (Department of Licensing and Regulatory Affairs, Bureau of Professional Licensing) regulates compounding pharmacies in Michigan. Compounded GLP-1 limited. How to check a pharmacy's license, plus verified listings.
Michigan at a glance
- Pharmacy regulator
- Michigan Board of Pharmacy (Department of Licensing and Regulatory Affairs, Bureau of Professional Licensing)
- 503A framework
- Follows the federal 503A framework
- Telehealth prescribing
- Regulatory: Telehealth allowed
- Asynchronous prescribing
- Regulatory: Async unclear
- Compounded GLP-1 access
- Regulatory: Compounded GLP-1 limited
Verified compounding pharmacies serving Michigan
No verified compounding pharmacies serving Michigan are listed yet. A provider appears here only after it passes the verification checklist, and those checks are still under way.
Looking for care now? Start with what the law allows where you live, then how a legitimate prescription works.
Run a pharmacy, clinic, or telehealth service? Apply for a listing.
Who regulates compounding pharmacies in Michigan
The Board of Pharmacy, housed in LARA, regulates pharmacy under Part 177 of the Public Health Code (MCL 333.17701 to 333.17780) and the Board of Pharmacy General Rules in the Michigan Administrative Code (Part 3, pharmacy licenses, R 338.531 to R 338.539, and Part 6, practice of pharmacy, R 338.582 to R 338.591). MCL 333.17748 requires a pharmacy, whether or not located in Michigan, to be licensed to do business in the state; MCL 333.17748e sets narrow conditions under which a licensed out-of-state pharmacy may deliver through a Michigan-licensed wholesale distributor-broker. After the 2012 compounding outbreak, Michigan enacted MCL 333.17748a (2014 Public Act 280, effective September 30, 2014), which requires a pharmacy that provides compounding services for sterile pharmaceuticals to hold current accreditation from a Board-approved national accrediting organization, or to show USP compliance in a manner the Board determines, to verify that status with each license renewal, and to notify the department within 30 days of a complaint from another state or a federal investigation about its compounding. Under R 338.533 the Board adopts USP chapters 795 and 797 (both revised 2023) as the compounding standards, and under R 338.534 an out-of-state pharmacy that will provide sterile compounded preparations in Michigan must have an inspection completed no more than 18 months before its initial or renewal application, by the department, a Board-recognized national inspection program, an approved accrediting organization, or its home-state licensing agency. Michigan has no state bulks list; peptide eligibility follows the federal 503A framework. [1] [2] [3] [4] [5] [6] [7]
Compounded GLP-1 access in Michigan
A telehealth GLP-1 program shipping compounded injections into Michigan must use a pharmacy that holds a Michigan pharmacy license under MCL 333.17748, which patients can check in the LARA license verification system. [1] [2] [10]
Research use only sellers in Michigan
Part 177 of the Public Health Code restricts the dispensing and sale of prescription drugs to licensed pharmacies and prescribers, and a seller of "research use only" injectable peptides to Michigan consumers holds no such license. [2] [11]
How to check a compounding pharmacy in Michigan
- Search the Michigan Board of Pharmacy (Department of Licensing and Regulatory Affairs, Bureau of Professional Licensing) license lookup for the pharmacy by name. A pharmacy based elsewhere needs whatever license or registration Michigan requires before it ships to you. [1] [2] [3] [4] [5] [6] [7]
- Ask whether it operates as a 503A pharmacy or a 503B outsourcing facility, and confirm a 503B claim against FDA's outsourcing facility information (see the verification checklist).
- Confirm the peptide can be lawfully compounded: check its status on the regulatory tracker or its peptide page before paying.
- Walk away from any seller that labels a peptide "research use only" or "not for human consumption". See the research use only section above for what that means in Michigan. [2] [11]
Common questions in Michigan
Can an out-of-state pharmacy ship compounded peptides to me in Michigan?
Generally only if it holds a Michigan pharmacy license. MCL 333.17748 requires any pharmacy doing business in Michigan to be licensed, whether or not it is located in the state. Check the pharmacy in the LARA license lookup before ordering. [1] [2]
Can a Michigan pharmacy compound BPC-157?
No, not from bulk today. BPC-157 is not on the 503A bulks list. PCAC's July 2026 recommendation is advisory, and until FDA publishes a final rule a 503A pharmacy has no federal basis to compound it from bulk. State boards cannot authorize what federal law does not. Peptides still in FDA Category 2 cannot be compounded either. [7] [8] [9]
Sources
- [1]Michigan Board of Pharmacy (LARA Bureau of Professional Licensing)
- [2]MCL 333.17748, Pharmacy, manufacturer, or wholesale distributor license required
- [3]MCL 333.17748a, Compounding services for sterile pharmaceuticals; accreditation
- [4]Mich. Admin. Code R 338.533, Compounding standards and requirements; outsourcing facilities
- [5]Mich. Admin. Code R 338.534, Out-of-state pharmacy licensure inspection; in-state renewal inspection
- [6]Michigan Board of Pharmacy General Rules, Part 3, Pharmacy licenses (R 338.531 to R 338.539)
- [7]FDA: Section 503A of the Federal Food, Drug, and Cosmetic ActFDA
- [8]FDA: Certain bulk drug substances for use in compounding may present significant safety risks (503A and 503B category lists)FDA
- [9]FDA: Pharmacy Compounding Advisory CommitteeFDA
- [10]FDA: concerns with unapproved GLP-1 drugs used for weight loss, including shortage resolution and compounding grace periodsFDA
- [11]21 U.S.C. 331, Prohibited acts